APTN Adaptin Bio, Inc.
Fundamentals / CIK 0001938571 / USDAdaptin Bio, Inc. reported $1.09M in total assets and a net loss of $4.68M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open APTN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$4.67M Operating profit
-
Net Income FY 2025-$4.68M GAAP bottom line
-
Diluted EPS FY 2025-$0.51 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$430K Total debt: --
Annual revenue and net income
3 fiscal years (2023 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Research & Development | $1.77M | $1.82M | -- |
| Total Operating Expenses | $5.41M | $2.57M | -- |
| Operating Income | -$5.41M | -$2.57M | -$86K |
| Interest Expense | $73K | $341K | -- |
| Income Before Tax | -$5.17M | -$3.12M | -- |
| Net Income | -$5.17M | -$3.12M | -$86K |
| Basic EPS | -$0.66 | -$0.96 | -$0.02 |
| Diluted EPS | -$0.66 | -$0.96 | -$0.02 |
| Basic Shares Outstanding | 7.8M | 3.2M | 5.0M |
| Diluted Shares Outstanding | 7.8M | 3.2M | 5.0M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $116K | $138K | $166K | $593K | $779K | $340K | $62K | $258K |
| Total Operating Expenses | $954K | $1.20M | $1.14M | $1.37M | $1.68M | $1.52M | $850K | $508K |
| Operating Income | -$954K | -$1.20M | -$1.14M | -$1.37M | -$1.68M | -$1.52M | -$850K | -$508K |
| Interest Expense | $3.0K | $4.7K | $1.9K | $0 | $0 | $0 | $73K | $146K |
| Income Before Tax | -$957K | -$1.21M | -$1.15M | -$1.37M | -$1.68M | -$1.52M | -$603K | -$857K |
| Net Income | -$957K | -$1.21M | -$1.15M | -$1.37M | -$1.68M | -$1.52M | -$603K | -$857K |
| Basic EPS | -$0.10 | -$0.14 | -$0.13 | -- | -$0.20 | -$0.18 | -$0.10 | -- |
| Diluted EPS | -$0.10 | -$0.14 | $0.13 | -- | -$0.20 | -$0.18 | $0.10 | -- |
| Basic Shares Outstanding | 9.2M | 8.8M | 8.7M | -- | 8.5M | 8.5M | 5.8M | -- |
| Diluted Shares Outstanding | 9.2M | 8.8M | 8.7M | -- | 8.5M | 8.5M | 5.8M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $459K | $34K | $380 | $500 |
| Cash & Short-Term Investments | $459K | $34K | $380 | $500 |
| Total Current Assets | $619K | $46K | $380 | $500 |
| Total Non-Current Assets | $0 | $194K | $0 | $0 |
| Total Assets | $619K | $239K | $380 | $500 |
| Accounts Payable | $1.51M | $1.36M | -- | -- |
| Total Current Liabilities | $2.11M | $4.34M | $113K | $28K |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 |
| Total Liabilities | $2.11M | $4.34M | $113K | $28K |
| Common Stock | $866 | $325 | $500 | $500 |
| Retained Earnings | -$9.29M | -$4.12M | -$113K | -$28K |
| Total Stockholders' Equity | -$1.49M | -$4.10M | -$978K | -$27K |
| Total Equity | -$1.49M | -$4.10M | -$978K | -$27K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $430K | $670K | $301K | $459K | $579K | $1.35M | $2.37M | $34K |
| Cash & Short-Term Investments | $430K | $670K | $301K | $459K | $579K | $1.35M | $2.37M | $34K |
| Total Current Assets | $1.09M | $981K | $706K | $619K | $979K | $1.66M | $2.85M | $46K |
| Total Non-Current Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $194K |
| Total Assets | $1.09M | $981K | $706K | $619K | $979K | $1.66M | $2.85M | $239K |
| Accounts Payable | $1.69M | $1.67M | $1.37M | $1.51M | $1.34M | $667K | $327K | $1.36M |
| Total Current Liabilities | $2.76M | $2.65M | $2.48M | $2.11M | $1.86M | $1.19M | $1.11M | $4.34M |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2.76M | $2.65M | $2.48M | $2.11M | $1.86M | $1.19M | $1.11M | $4.34M |
| Common Stock | $926 | $905 | $879 | $866 | $846 | $846 | $840 | $325 |
| Retained Earnings | -$12.60M | -$11.64M | -$10.44M | -$9.29M | -$7.92M | -$6.25M | -$4.73M | -$4.12M |
| Total Stockholders' Equity | -$1.67M | -$1.67M | -$1.78M | -$1.49M | -$881K | $474K | $1.75M | -$4.10M |
| Total Equity | -$1.67M | -$1.67M | -$1.78M | -$1.49M | -$881K | $474K | $1.75M | -$4.10M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Net Income | -$5.17M | -$3.12M | -$86K |
| Stock-Based Compensation | $497K | -- | -- |
| Change in Payables | $497K | $1.08M | -- |
| Operating Cash Flow | -$4.78M | -$649K | -$81K |
| Financing Cash Flow | $5.20M | $679K | $81K |
| Net Change in Cash | $425K | $29K | -$120 |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$957K | -$1.21M | -$1.15M | -$1.37M | -$1.68M | -$1.52M | -$603K | -$857K |
| Stock-Based Compensation | $184K | $194K | $345K | -- | $320K | -- | -- | -- |
| Change in Payables | $42K | $260K | -$141K | $174K | $672K | $340K | -$688K | $430K |
| Operating Cash Flow | -$965K | -$450K | -$596K | -$703K | -$772K | -$1.02M | -$2.28M | $113K |
| Common Stock Issued | $0 | $260K | $652K | -- | -- | -- | -- | -- |
| Financing Cash Flow | $724K | $819K | $438K | $583K | $0 | $0 | $4.62M | -$194K |
| Net Change in Cash | -$240K | $369K | -$158K | -$120K | -$772K | -$1.02M | $2.34M | -$81K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Return on Assets (ROA) | -834.6% | -1304.2% | -22524.5% |
| Current Ratio | 0.29x | 0.01x | 0.00x |
| Quick Ratio | 0.22x | 0.01x | 0.00x |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -861.8% | -194.0% | -- |
| Return on Assets (ROA) | -430.0% | -549.7% | -808.7% | -834.6% | -475.4% | -245.9% | -118.6% | -1304.2% |
| Current Ratio | 0.39x | 0.37x | 0.28x | 0.29x | 0.53x | 1.40x | 2.57x | 0.01x |
| Quick Ratio | 0.16x | 0.25x | 0.12x | 0.22x | 0.31x | 1.14x | 2.14x | 0.01x |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -723.9% | -- | -- | -- | -- |